North Cell Pharmaceutical has developed a technology platform of patented ingredients (Skin Resuscitation Factor SRF) that can down regulate inflammation (eliminate the destruction of nitric oxide to peroxynitrite), to enhance healing or to up regulate nitric oxide that can be used by the human body to kill bacterial, viral, and fungal infections and tumors. SRF can be used independently to create new products or can be added to existing products to enhance efficacy and to generate new product claims.
North Cell and GlaxoSmithKline Sign Agreement
North Cell Pharmaceutical, Inc. and GlaxoSmithKline Consumer Healthcare have entered into an Option and Development Agreement regarding North Cells Skin Resuscitation FactorTM (SRFTM ) technology for use in certain applications. . .